THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:TN8 • US8835561023

484.5 EUR
-6.35 (-1.29%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

4

TN8 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. TN8 has an average financial health and profitability rating. TN8 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year TN8 was profitable.
  • TN8 had a positive operating cash flow in the past year.
  • Of the past 5 years TN8 4 years were profitable.
  • TN8 had a positive operating cash flow in 4 of the past 5 years.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • TN8 has a Return On Assets of 6.38%. This is in the better half of the industry: TN8 outperforms 77.78% of its industry peers.
  • TN8 has a better Return On Equity (12.88%) than 77.78% of its industry peers.
  • TN8's Return On Invested Capital of 6.43% is in line compared to the rest of the industry. TN8 outperforms 55.56% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TN8 is below the industry average of 9.98%.
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROIC 6.43%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of TN8 (15.02%) is better than 83.33% of its industry peers.
  • In the last couple of years the Profit Margin of TN8 has remained more or less at the same level.
  • TN8 has a better Operating Margin (18.40%) than 72.22% of its industry peers.
  • In the last couple of years the Operating Margin of TN8 has grown nicely.
  • TN8 has a Gross Margin (41.43%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of TN8 has remained more or less at the same level.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
  • There is no outstanding debt for TN8. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • TN8 has a debt to FCF ratio of 5.84. This is a neutral value as TN8 would need 5.84 years to pay back of all of its debts.
  • TN8 has a better Debt to FCF ratio (5.84) than 61.11% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that TN8 is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, TN8 is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Altman-Z N/A
ROIC/WACC0.61
WACC10.6%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that TN8 should not have too much problems paying its short term obligations.
  • TN8's Current ratio of 1.50 is fine compared to the rest of the industry. TN8 outperforms 66.67% of its industry peers.
  • TN8 has a Quick Ratio of 1.11. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of TN8 (1.11) is better than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.11
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.62% over the past year.
  • TN8 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.19% yearly.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.2%

3.2 Future

  • Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.96% on average per year.
  • TN8 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.93% yearly.
EPS Next Y8.69%
EPS Next 2Y9.63%
EPS Next 3Y10.69%
EPS Next 5Y10.96%
Revenue Next Year5.08%
Revenue Next 2Y5.3%
Revenue Next 3Y5.23%
Revenue Next 5Y4.93%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.04 indicates a quite expensive valuation of TN8.
  • Based on the Price/Earnings ratio, TN8 is valued a bit cheaper than 61.11% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of TN8 to the average of the S&P500 Index (28.25), we can say TN8 is valued inline with the index average.
  • A Price/Forward Earnings ratio of 23.04 indicates a rather expensive valuation of TN8.
  • TN8's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TN8 is cheaper than 61.11% of the companies in the same industry.
  • TN8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.04
Fwd PE 23.04
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • TN8's Enterprise Value to EBITDA ratio is in line with the industry average.
  • TN8's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 35.21
EV/EBITDA 22.66
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
  • TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.88
PEG (5Y)7.86
EPS Next 2Y9.63%
EPS Next 3Y10.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • TN8 has a yearly dividend return of 0.29%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.43, TN8 has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.29, TN8 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

  • On average, the dividend of TN8 grows each year by 15.42%, which is quite nice.
Dividend Growth(5Y)15.42%
Div Incr Years4
Div Non Decr Years4
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • TN8 pays out 9.48% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of TN8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y9.63%
EPS Next 3Y10.69%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (2/4/2026, 7:00:00 PM)

484.5

-6.35 (-1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners92.78%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap182.03B
Revenue(TTM)N/A
Net Income(TTM)6.57B
Analysts83.13
Price Target563.72 (16.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend1.27
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)2.04%
PT rev (3m)16.62%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-1.18%
EPS NY rev (1m)0%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 25.04
Fwd PE 23.04
P/S 4.92
P/FCF 35.21
P/OCF 28.13
P/B 4.22
P/tB N/A
EV/EBITDA 22.66
EPS(TTM)19.35
EY3.99%
EPS(NY)21.03
Fwd EY4.34%
FCF(TTM)13.76
FCFY2.84%
OCF(TTM)17.23
OCFY3.56%
SpS98.48
BVpS114.9
TBVpS-32.66
PEG (NY)2.88
PEG (5Y)7.86
Graham Number223.66
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROCE 9.13%
ROIC 6.43%
ROICexc 6.7%
ROICexgc 29.73%
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
FCFM 13.97%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Debt/EBITDA 2.94
Cap/Depr 55.1%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 70.55%
Profit Quality 93%
Current Ratio 1.5
Quick Ratio 1.11
Altman-Z N/A
F-Score8
WACC10.6%
ROIC/WACC0.61
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.69%
EPS Next 2Y9.63%
EPS Next 3Y10.69%
EPS Next 5Y10.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.2%
Revenue Next Year5.08%
Revenue Next 2Y5.3%
Revenue Next 3Y5.23%
Revenue Next 5Y4.93%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year15.31%
EBIT Next 3Y9.31%
EBIT Next 5Y9.16%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%

THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ

What is the fundamental rating for TN8 stock?

ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.


What is the valuation status for TN8 stock?

ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.


What is the profitability of TN8 stock?

THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for TN8 stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 4 / 10.


Can you provide the dividend sustainability for TN8 stock?

The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.48%.